CASES OF NOTEAngiotensin-Converting Enzyme Inhibitor AngioedemaBankston, Josh MSN, CRNP, FNP-BC, NRP, CEN, CTRN, FP-C; House, David Thomas DNP, CRNP, FNP-BC, ENP-C, CNSEditor(s): Jordan, Kathleen S. DNP, RN, FNP-BC, ENP-C, SANE-P, FAEN, FAANP, Column Editor Author Information University of Alabama at Birmingham School of Nursing. Corresponding Author: Josh Bankston, MSN, CRNP, FNP-BC, NRP, CEN, CTRN, FP-C, University of Alabama at Birmingham School of Nursing, 1701 University Blvd, Birmingham, AL 35294 (email@example.com). Disclosure: The authors report no conflicts of interest. Advanced Emergency Nursing Journal: April/June 2020 - Volume 42 - Issue 2 - p 103-107 doi: 10.1097/TME.0000000000000294 Buy Take the CE Test Metrics Abstract Angioedema from angiotensin-converting enzyme inhibitors (ACEIs) is a potential, emergent, and frightening problem that presents to the emergency department. This article focuses on angioedema caused by using ACEIs. The presentation, pathology, diagnostic testing, treatment, and patient education of angioedema are explored. This article explores using fresh frozen plasma as an initial approach to the treatment of ACEI angioedema. © 2020 Wolters Kluwer Health, Inc. All rights reserved.